-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
-
Summary
-
Rani Therapeutics Holdings, Inc. quarterly and annual General and Administrative Expense history and change rate from Q2 2020 to Q3 2025.
- Rani Therapeutics Holdings, Inc. General and Administrative Expense for the quarter ending 30 Sep 2025 was $4,036,000, a 28.3% decline year-over-year.
- Rani Therapeutics Holdings, Inc. General and Administrative Expense for the twelve months ending 30 Sep 2025 was $20,113,000, a 17.3% decline year-over-year.
- Rani Therapeutics Holdings, Inc. annual General and Administrative Expense for 2024 was $23,946,000, a 9.55% decline from 2023.
- Rani Therapeutics Holdings, Inc. annual General and Administrative Expense for 2023 was $26,475,000, a 1.38% decline from 2022.
- Rani Therapeutics Holdings, Inc. annual General and Administrative Expense for 2022 was $26,844,000, a 3.56% decline from 2021.
General and Administrative Expense, Trailing 12 Months (USD)
General and Administrative Expense, Quarterly (USD)
General and Administrative Expense, YoY Quarterly Change (%)
General and Administrative Expense, Annual (USD)
General and Administrative Expense, YoY Annual Change (%)